Invention Grant
- Patent Title: Compounds for treatment of cell proliferative diseases
- Patent Title (中): 用于治疗细胞增殖性疾病的化合物
-
Application No.: US14147089Application Date: 2014-01-03
-
Publication No.: US09096499B2Publication Date: 2015-08-04
- Inventor: Waldemar Priebe , Nicholas Donato , Moshe Talpaz , Slawomir Szymanski , Izabela Fokt , Alexander Levitzki
- Applicant: Board of Regents, The University of Texas System
- Applicant Address: US TX Austin
- Assignee: Board of Regents, The University of Texas System
- Current Assignee: Board of Regents, The University of Texas System
- Current Assignee Address: US TX Austin
- Agency: Parker Highlander PLLC
- Main IPC: C07C255/44
- IPC: C07C255/44 ; C07C255/41 ; C07C255/42 ; C07D213/57 ; C07D213/61 ; A61K31/277 ; A61K45/06
Abstract:
The present invention concerns compounds and their use to treat cell proliferative diseases such as cancer. Compounds of the present invention display significant potency as kinase inhibitors, cause the downregulation of c-myc, and inhibit the growth and survival of cancerous cell lines.
Public/Granted literature
- US20140329901A1 COMPOUNDS FOR TREATMENT OF CELL PROLIFERATIVE DISEASES Public/Granted day:2014-11-06
Information query
